LC15-0444 50mg qd

DRUG2 trials

Sponsors

LG Life Sciences

Conditions

Type 2 Diabetes Mellitus

Phase 3

Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes

CompletedNCT01601990

LG Life SciencesType 2 Diabetes Mellitus

Start: 2009-12-31End: 2011-11-30Updated: 2012-05-18

Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes

CompletedNCT01602003

LG Life SciencesType 2 Diabetes Mellitus

Start: 2009-12-31End: 2012-05-31Updated: 2012-05-18